Back
Apellis Pharmaceuticals Stock Price Chart
The truth about AI stocks (must see)
Learn the names of all 10 stocks here. FREE.
Sell
36
APLS
Apellis Pharmaceuticals
Last Price:
$19.59
Seasonality Move:
-15.15%
7 Day Trial
ALL ACCESS PASS
$
7
The Best 10 AI Stocks to Own in 2025
Discover this under-the-radar AI stock now, ahead of the crowd.-
The current trend is moderately bullish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.
Apellis Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.72 | Buy |
| 20-day SMA: | 18.91 | Buy |
| 50-day SMA: | 18.4 | Buy |
| 200-day SMA: | 24.87 | Sell |
| 8-day EMA: | 19.69 | Buy |
| 20-day EMA: | 19.21 | Buy |
| 50-day EMA: | 19.11 | Buy |
| 200-day EMA: | 25.31 | Sell |
Apellis Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.43 | Buy |
| Relative Strength Index (14 RSI): | 60 | Buy |
| Chaikin Money Flow: | 2798192 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.78 - 19.68) | Buy |
| Bollinger Bands (100): | (17.2 - 22.56) | Buy |
Apellis Pharmaceuticals Technical Analysis
| Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 11 | 14 | 15 | 16 | 17 | 18 | 21 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Apellis Pharmaceuticals Stock
Is Apellis Pharmaceuticals Stock a Buy?
-
Apellis Pharmaceuticals share price is 20.09 while APLS 8-day simple moving average is 19.72, which is a Buy signal.
-
The stock price of APLS is 20.09 while Apellis Pharmaceuticals 20-day SMA is 18.91, which makes it a Buy.
-
Apellis Pharmaceuticals 50-day simple moving average is 18.40 while APLS share price is 20.09, making it a Buy technically.
-
APLS stock price is 20.09 and Apellis Pharmaceuticals 200-day simple moving average is 24.87, creating a Sell signal.
APLS Technical Analysis vs Fundamental Analysis
Sell
36
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy or a Sell?
-
Apellis Pharmaceuticals stock is rated a SellThe current Apellis Pharmaceuticals [APLS] share price is $20.09. The Score for APLS is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
Apellis Pharmaceuticals Stock Info
Market Cap:
2.5B
Price in USD:
20.09
Share Volume:
4.6M
Apellis Pharmaceuticals 52-Week Range
52-Week High:
41.94
52-Week Low:
16.10
Sell
36
Apellis Pharmaceuticals (APLS)
is a Sell
Apellis Pharmaceuticals Share Price Forecast
-
What is the Apellis Pharmaceuticals stock price today?The Apellis Pharmaceuticals stock price is 20.09 USD today.
-
Will APLS stock go up or go down?Apellis Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Apellis Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Apellis Pharmaceuticals is overvalued.
Is Apellis Pharmaceuticals Stock a Buy?
-
Apellis Pharmaceuticals share price is 20.09 while APLS 8-day exponential moving average is 19.69, which is a Buy signal.
-
The stock price of APLS is 20.09 while Apellis Pharmaceuticals 20-day EMA is 19.21, which makes it a Buy.
-
Apellis Pharmaceuticals 50-day exponential moving average is 19.11 while APLS share price is 20.09, making it a Buy technically.
-
APLS stock price is 20.09 and Apellis Pharmaceuticals 200-day simple moving average is 25.31, creating a Sell signal.
Fundamental Analysis of Apellis Pharmaceuticals
Is Apellis Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.38 per share, a decrease next quarter of $0.39 per share, an increase this year of $0.45 per share, and an increase next year of $0.39 per share.
Technical Analysis of Apellis Pharmaceuticals
Should I short Apellis Pharmaceuticals stock?
-
APLS Moving Average Covergence Divergence (MACD) indicator is 0.43, suggesting Apellis Pharmaceuticals is a Buy
-
Apellis Pharmaceuticals Relative Strength Index (RSI) is 60, which suggest Apellis Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Apellis Pharmaceuticals is (17.78 - 19.68), which suggest Apellis Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Apellis Pharmaceuticals is (17.2 - 22.56), which suggest Apellis Pharmaceuticals is a Buy
* Apellis Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.